Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
about
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryHematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatmentGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.Thrombocytopenia and hemostatic disorders in chronic graft versus host disease.Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisRenal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation.Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsOutcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation.Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientAlterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complicationsCyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat).The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.Neurological complications of transplantation: part I: hematopoietic cell transplantation.Therapeutic apheresis for patients with cancer.Onco-nephrology: current concepts and future perspectives.Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.
P2860
Q26992169-F17773BF-E659-4F9D-A9E4-FA0F3FFFE01AQ28069228-31C87FFF-E2D2-40DA-B683-C80EDC231D18Q30276550-361D0E21-87E8-48D8-B52E-F50F64E8D6BEQ33384578-88A0DA43-A438-40A6-9CE1-09D1A30F60CBQ33385836-BEA8D73B-18D3-4D45-8554-F5E0D3DEFCA7Q33386036-B9BA8F7B-D524-4AD3-89B0-FE4E9F9ABE20Q33386308-2B2373E6-AD4A-4645-9F45-F21AE5367A76Q33391308-1CA76D35-AA37-4069-8CB1-16394DCF2EE4Q33392710-FB124AFA-6E19-44C5-8D5D-EDFD773D6037Q33393068-13B99E1D-83EF-4BC5-9B67-150C343D1A31Q33393944-3A839270-B310-4072-853B-B57C1D10AD11Q33394558-F1262333-60EE-4275-BBE7-DC2ED65B9136Q33395998-5C331F7A-113B-4889-BF07-0DD27591C567Q33396969-E87E7F09-071F-438F-A112-57B93A0D1326Q33398627-CCEC6577-2B00-4A10-BC2F-DA28E01ECD2BQ33402385-C1D500E8-C03D-4FB7-BEFE-D4B62B19D431Q33403897-975AE3C2-2AA3-4BCC-8915-8CBA4B4562D2Q33407913-905AE2CD-DDD7-49EF-A4A2-D09BBE11F8A9Q33409874-384A6127-10EA-4BA9-846C-1FA789045480Q33412325-BC1AFE73-B361-4285-BF4D-4D50E847A638Q33413498-3B3CBFF7-A66E-4595-876A-E2F68543D111Q33415603-F7FF64EF-9B6D-4FEE-AD2E-889361F47C9AQ33417690-82488A59-22FC-4503-853F-08062E467547Q33418635-46565900-CB49-475D-9B1B-EC2F23FB8F21Q33420131-22754C53-BA44-4691-84EE-404E87FB7D2CQ33420858-B3891A0E-898C-40B6-A796-C8D74DE7C0C9Q33421514-C3B73DAA-1EE5-49A5-9A59-2F1309569C6DQ33424153-2A37F687-A0D4-425D-8CCD-15F7960150D1Q33424902-55181952-49FC-49BC-9A94-A1D0482F8B4BQ33428744-83D21B8F-1847-421E-A2FE-8F7CCAD689DEQ34122035-00A1E9C2-A5F9-4162-A003-C625EBD231CAQ34448474-42D7E473-F988-40CD-8FFB-B1FF697718BBQ34522746-45CC2D99-7764-4745-BF67-AC8ADBCE9E25Q35200663-8A7B740D-FBA5-4811-ABA0-5156DBD26A01Q36492812-8738F6AD-5CC1-4FF5-B9FD-689095843D61Q36862464-1DCB74D1-8756-4745-8C76-6FE0CC366384Q38132157-7E56D000-2B31-4093-AF92-3F9C7DDBB389Q38287610-03206DF7-3219-4AB4-9F43-9AA0E0C9D997Q38382457-D39DCD6E-DA74-4552-83F3-BC5145C30583Q38709053-AF740BC7-F206-45CF-91E8-806805FCF99E
P2860
Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Diagnosis and treatment of tra ...... gress or are we still waiting?
@ast
Diagnosis and treatment of tra ...... gress or are we still waiting?
@en
type
label
Diagnosis and treatment of tra ...... gress or are we still waiting?
@ast
Diagnosis and treatment of tra ...... gress or are we still waiting?
@en
prefLabel
Diagnosis and treatment of tra ...... gress or are we still waiting?
@ast
Diagnosis and treatment of tra ...... gress or are we still waiting?
@en
P2860
P356
P1476
Diagnosis and treatment of tra ...... gress or are we still waiting?
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705758
P407
P577
2007-07-02T00:00:00Z
P5875
P6179
1043147565